Division of Ophthalmology, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware 19803, USA.
Curr Opin Ophthalmol. 2010 Sep;21(5):329-34. doi: 10.1097/ICU.0b013e32833cd40b.
To evaluate and review the recent scientific literature on retinopathy of prematurity (ROP). Recent studies have shown advancement in treatment options in ROP as well as improved functional and structural outcomes. This review compiles some of these recent findings.
New guidelines on ROP screening and treatment criteria have recently been developed and are now the standard of care for practitioners taking care of children having ROP. Recent advances in antiangiogenic therapies offer possible primary or adjunct treatment to the well established and effective laser treatment options. Follow-up of treated ROP patients informs us of the short-term and long-term complications requiring lifetime ophthalmology care.
This review offers an update on the screening and treatment guidelines, new treatment options, and short-term and long-term complications in ROP.
评估和回顾早产儿视网膜病变（ROP）的最新科学文献。最近的研究表明，ROP 的治疗选择取得了进展，功能和结构结果得到了改善。本综述汇集了其中的一些最新发现。
ROP 筛查和治疗标准的新指南最近已经制定，并成为治疗 ROP 患儿的医生的护理标准。抗血管生成治疗的最新进展为已经确立的有效激光治疗选择提供了可能的主要或辅助治疗方法。对接受治疗的 ROP 患者的随访告知我们需要终身眼科护理的短期和长期并发症。
本综述介绍了 ROP 的筛查和治疗指南、新的治疗选择以及短期和长期并发症的最新进展。
